Sepsitron Company
%20.jpg)
Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.
Technology:
Biomarkers
Headquarters:
Singapore
Funding Status:
Seed
Founded Date:
11-1
Last Funding Type:
Pre-Seed
Last Funding Date:
43913
Employee Number:
43840
Total Funding:
6-21
Industry:
Hardware, Medical Device
Investor Type:
For Profit